Key facts
- This page summarizes Eugene M. Johnston's Form 4 filing for MANGOCEUTICALS, INC. (MGRX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 06 Oct 2026, 08:00.
Eugene M. Johnston - 28 Jul 2026 Form 4 Insider Report for MANGOCEUTICALS, INC. (MGRX)
- SEC form
- 4
- Accepted by SEC
- 06 Oct 2026, 08:00:19 UTC
- Prior SEC filing
- 17 Dec 2025
- Next SEC filing
- 09 Oct 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Eugene M Johnston
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Eugene M. Johnston filed Form 4 for MANGOCEUTICALS, INC. (MGRX) on 06 Oct 2026.
Change
- Previous filing in this sequence was filed on 17 Dec 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001254538
Primary reporting owner
JOHNSTON EUGENE M
- Relationship
- CFO
- Address
- C/O MANGOCEUTICALS, INC., 17130 DALLAS PKWY STE 240, DALLAS
- Signature
- /s/ Eugene M Johnston
- Signature date
- 06 Oct 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MGRX
transaction
Common Stock
Award
- Transaction value
- Shares
- +100,000
- Change %
- +83%
- Price
- $0.000000*
- Shares after
- 220,000
- Date
- 28 Jul 2026
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Issued in consideration for services rendered as Chief Financial Officer of the Issuer.